Search results

• Responsible drug use (redirect from Harm reduction practices)
  using psychoactive substances. The first section covers general harm reduction practices for all substance classes while the latter is specific to hallucinogens
  37 KB (3,944 words) - 23:17, 21 April 2024
• PsychonautWiki (category PsychonautWiki)
  extensive content collection covering the scientific research and harm reduction practices relevant to hallucinogen and general psychoactive substance experimentation
  9 KB (986 words) - 06:53, 29 April 2024
• 3-MeO-PCE (section Toxicity and harm potential)
  history of human usage. It is strongly recommended that one use harm reduction practices if using this substance. 3-MeO-PCE, or N-Ethyl-1-(3-methoxyphe
  20 KB (2,787 words) - 17:34, 17 March 2024
• 3-HO-PCP (section Toxicity and harm potential)
  toxicity profile, it is strongly recommended that one use proper harm reduction practices if choosing to use this substance. 3-HO-PCP was first synthesized
  20 KB (2,510 words) - 17:29, 17 March 2024
• 3-HO-PCE (section Toxicity and harm potential)
  arylcyclohexylamines, it is strongly recommended that one use proper harm reduction practices if choosing to use this substance. On October 18, 2012 the Advisory
  16 KB (2,138 words) - 20:47, 21 July 2022
• PCP (section Toxicity and harm potential)
  (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
  25 KB (3,130 words) - 14:33, 16 April 2024
• 4-FA (section Toxicity and harm potential)
  toxicity profile, it is strongly recommended that one use proper harm reduction practices if choosing to use this substance. 4-Fluoroamphetamine (4-FA) is
  21 KB (3,439 words) - 15:42, 30 July 2022
• Synthetic cannabinoid (section Toxicity and harm potential)
  more severe health risks than others. It is highly advised to use harm reduction practices if using these substances. Popular herb blends include K2 and Spice
  20 KB (2,224 words) - 22:50, 21 April 2024
• 25D-NBOMe (section Toxicity and harm potential)
  psychedelic substance with the proper amount of precaution and harm reduction practices when using it. 25D-NBOMe, or 2C-D-NBOMe, is a serotonergic N-benzyl
  19 KB (3,278 words) - 19:48, 19 July 2022
• 25N-NBOMe (section Toxicity and harm potential)
  psychedelic substance with the proper amount of precaution and harm reduction practices if using it. 25N-NBOMe or 2C-N-NBOMe is a serotonergic N-benzyl
  18 KB (3,141 words) - 20:58, 19 July 2022
• 25C-NBOMe (section Toxicity and harm potential)
  be overly difficult to use safely. It is highly advised to use harm reduction practices if using this substance. 25C-NBOMe or 2C-C-NBOMe is a serotonergic
  26 KB (4,063 words) - 23:35, 21 April 2024
• Amphetamine (section Toxicity and harm potential)
  pressure and increased risk of stroke. It is highly advised to use harm reduction practices if using this substance. Amphetamine was first synthesized in Germany
  41 KB (5,610 words) - 19:01, 7 April 2024
• Methamphetamine (section Harm reduction)
  elevated risk of stroke and heart attack. It is highly advised to use harm reduction practices if using this substance. Amphetamine was first synthesized in 1887
  41 KB (5,798 words) - 13:29, 16 April 2024
• 25B-NBOMe (section Toxicity and harm potential)
  difficult to use safely. Therefore it is highly advised to use harm reduction practices if using this substance. 25B-NBOMe or 2C-B-NBOMe is a serotonergic
  19 KB (3,287 words) - 22:22, 19 July 2022
• 3-MeO-PCP (section Toxicity and harm potential)
  effects and lack of research, it is strongly advised to use use harm reduction practices if using this substance. 3-Methoxyphencyclidine, or 3-MeO-PCP,
  25 KB (3,520 words) - 21:44, 6 May 2024
• 2C-B (section Toxicity and harm potential)
  those predisposed to mental disorders. It is highly advised to use harm reduction practices if using this substance. 2C-B was first synthesized and tested
  36 KB (4,745 words) - 16:35, 7 April 2024
• MDMA (section Harm reduction)
  delayed orgasm (see subjective effects). It is highly advised to use harm reduction practices if using this substance. MDMA was first synthesized in 1912 by
  85 KB (10,499 words) - 14:24, 16 April 2024
• 25x-NBOMe (section Toxicity and harm potential)
  ISSN 0378-4274.  https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0190_disp.jpg https://psychonautwiki.org/wiki/File:Nbome_death_news_i2013e0191_disp
  6 KB (1,847 words) - 00:06, 16 May 2024
• MDPV (section Toxicity and harm potential)
  reported by nine European countries. It is highly advised to use harm reduction practices if using this substance. MDPV, or 3,4-Methylenedioxypyrovalerone
  23 KB (3,267 words) - 23:45, 21 April 2024
• Deliriant
  repeat the experience due to its unpleasant nature. Please use harm reduction practices if using this substance (e.g. starting with a low dose and always
  11 KB (1,021 words) - 23:00, 21 April 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)